Rekvina Laboratories Schedules Board Meeting for 13th Nov'26 to Consider Q2 Results
Rekvina Laboratories Ltd 路 Intimation 路 13 Nov 2026, 5:30 am
Rekvina Laboratories Schedules Board Meeting for 13th Nov'26 to Consider Q2 Results Rekvina Laboratories Limited has scheduled a meeting of its Board of Directors on 13th Nov'26 to consider and approve the unaudited Ind AS financial results for the quarter and half-year ended 30th Sep'26. In compliance with insider trading regulations, the trading window for designated persons has been closed from 1st Oct'26 and will reopen 48 hours after the declaration of the financial results.
Original exchange filing (PDF)
More announcements from Rekvina Laboratories Ltd
- Reg. 32 Statement of Deviation & Variation 路 13 Nov 2026
- Appointment of Ms. Bhagyshree as a company Secretary and Compliance Officer w.e.f. 16.11.2026. 路 13 Nov 2026
- Financial Result for QTR2 路 13 Nov 2026
- Outcome of Board Meeting 路 13 Nov 2026
- Intimation regarding Temporary Shutdown of Manufacturing Facility for Renovation, Upgradation and Installation of an Additional Vial Manufacturing Line. 路 27 Oct 2026
- Appointment of Mr. Subrata Samanta as a Chief Financial officer of the company with effect from 07.10.2026. 路 08 Oct 2026
- AGM Voting Results along-with Scrutinizer Report on E-Voting 路 30 Sept 2026
- Summary of Proceeding of Annual General Meeting 路 29 Sept 2026
